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fying the plant cellulose to produce fermentable sugars. The 
method can also include fermenting the fermentable sugars to 
produce alcohol. A method of producing a plant having ben 
e?cial sacchari?cation properties includes introducing into a 
plant a polynucleotide encoding a CESA polypeptide variant 
having at least one amino acid mutation in its carboxy-terrni 
nal transmembrane region; and expressing in the plant the 
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plant expressing the CESA polypeptide variant has bene?cial 
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PLANTS AND PLANT PRODUCTS USEFUL 
FOR BIOFUEL MANUFACTURE AND 
FEEDSTOCK, AND METHODS OF 
PRODUCING SAME 
RELATED APPLICATIONS 
This application claims priority from US. Provisional 
Application Ser. No. 61/097,361 ?led Sep. 16, 2008, the 
entire disclosure of Which is incorporated herein by this ref 
erence. 
TECHNICAL FIELD 
The presently disclosed subject matter relates to methods 
of selecting and/or producing plants having a bene?cial sac 
chari?cation properties. Plant cellulose or biomass obtained 
from plants having the bene?cial sacchari?cation properties 
can be more easily and e?iciently converted to a useful bio 
fuel, and can be used as feedstock having improved digest 
ibility. 
INTRODUCTION 
Plants use atmospheric carbon and sunlight during photo 
synthesis to produce their biomass (1), of Which a majority is 
sugar polymers stored in the plant cell Wall (2). Utilization of 
these sugar polymers is an attractive form of reneWable 
energy, With particular interest in the production of alcohol 
from cellulosic biomass (2). Approximately 180 billion tons 
of cellulose are produced by plants per annum, forming the 
most abundant organic polymer on the planet (3). However, 
recalcitrance of cellulose to sacchari?cation presents a major 
technical hurdle to overcome if cost-effective biochemical 
conversion of lignocellulosic biomass into bio fuels is to be 
realiZed. 
Current best practices use costly chemical pretreatments to 
convert lignocellulo sic material to fermentable sugars (2). 
Along these lines, another potentially advantageous modi? 
cation to the cell Wall lies in changing the high-order crystal 
line structure of cellulose, Which is formed of individual (1 -4) 
linked [3-D-glucosyl residues that coalesce via hydrogen 
bonding to form cellulose micro ?brils. 
A de?ning feature of the plant cell is a rigid cell Wall that 
constrains internal turgor pressure and yet must possess a 
degree of elasticity in order to alloW the cell to groW and 
acquire shape (5). The central load bearing component of the 
cell Wall is cellulose micro?brils, Which are often highly 
organiZed With respect to groWth pattern and cell shape (6). 
Synthesis of cellulose micro?brils occurs via a complex of 
plasma membrane-localized proteins containing several 
structurally similar cellulose synthase (CESA) subunits (6) 
that can be visualiZed as symmetrical rosettes of six globular 
complexes approximately 25-30 nm in diameter (FIG. 1D) 
(7). The only knoWn components of the cellulose synthase 
complex in higher plants are the CESA proteins, 10 genes of 
Which have been identi?ed in the sequenced genome of Am 
bidopsis Zhaliana (7). The only knoWn components of the 
cellulose synthase complex in higher plants are the CESA 
proteins (7). 
Tight bonding capacity of the hydroxyl groups via hydro 
gen bonding are critical to determining hoW the crystal struc 
ture of cellulose forms and also in directing important physi 
cal properties of cellulose materials (8). It is postulated that 
the chains of glucosyl residues in the ?bril periodically fail to 
coalesce into an ordered crystalline structure; these amor 
phous Zones along the ?bril length can possibly serve the 
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2 
association betWeen hemicellulose and cellulose ?brils (5). 
Indeed, the regulation of amorphous to crystalline Zones in 
the cellulose micro ?bril and the potential for biological regu 
lation has important connotations for plant design and cellu 
lose bioconversion, but as yet this area of research is poorly 
understood. 
Thus, there remains a need for increasing the availability of 
cellulose from plants for conversion into fermentable glucose 
for use in the production of ethanol and other biomass energy 
sources. 
SUMMARY 
The presently-disclosed subject matter meets some or all of 
the above-identi?ed needs, as Will become evident to those of 
ordinary skill in the art after a study of information provided 
in this document. 
This Summary describes several embodiments of the pres 
ently-disclosed subject matter, and in many cases lists varia 
tions and permutations of these embodiments. This Summary 
is merely exemplary of the numerous and varied embodi 
ments. Mention of one or more representative features of a 
given embodiment is likeWise exemplary. Such an embodi 
ment can typically exist With or Without the feature(s) men 
tioned; likeWise, those features can be applied to other 
embodiments of the presently-disclosed subject matter, 
Whether listed in this Summary or not. To avoid excessive 
repetition, this Summary does not list or suggest all possible 
combinations of such features. 
The presently-disclosed subject matter includes a method 
of processing plant cellulose, Which includes providing plant 
cellulose that is from a plant expressing a CESA polypeptide 
variant having at least one amino acidmutation in its carboxy 
terminal transmembrane region, and saccharifying the plant 
cellulose to produce fermentable sugars. In some embodi 
ments, the method also includes fermenting the fermentable 
sugars to produce alcohol. 
In some embodiments, the CESA polypeptide variant is a 
CESA selected from: CESA-1 polypeptide variant, CESA-2 
polypeptide variant, CESA-3 polypeptide variant, CESA-4 
polypeptide variant, CESA-5 polypeptide variant, CESA-6 
polypeptide variant, CESA-7 polypeptide variant, CESA-8 
polypeptide variant, CESA-9 polypeptide variant, and 
CESA-10 polypeptide variant. In some embodiments, the 
CESA polypeptide variant is a CESA selected from: CESA-1 
polypeptide variant, CESA-3 polypeptide variant, and 
CESA-6 polypeptide variant. In some embodiments, the 
CESA polypeptide variant is a CESA selected from: CESA-1 
polypeptide variant and CESA-3 polypeptide variant. In 
some embodiments, the CESA polypeptide variant is 
CESA-1 polypeptide variant. In some embodiments, the 
CESA polypeptide variant is CESA-3 polypeptide variant. 
In some embodiments, the CESA polypeptide variant 
includes at least one substitution at an amino acid from 840 
1065 of the CESA polypeptide, Where residue numbers 840 
1065 refer to those residues of full-length Wild type CESA 
polypeptide. In some embodiments, the CESA polypeptide 
variant includes at least one substitution at an amino acid 
from 900-1065. For example, in some embodiments, the at 
least one amino acid mutation includes a substitution at 
amino acid 942. In some embodiments, the at least one amino 
acid mutation includes a substitution at amino acid 942 from 
threonine to isoleucine. In some embodiments, the at least 
one amino acid mutation includes a substitution at amino acid 
998. In some embodiments, the at least one amino acid muta 
tion includes a substitution at amino acid 998 from glycine to 
aspartic acid. In some embodiments, the at least one amino 
US 8,383,888 B1 
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acid mutation includes a substitution at amino acid 903. In 
some embodiments, the at least one amino acid mutation 
includes a substitution at amino acid 903 from alanine to 
valine. In some embodiments, the at least one amino acid 
mutation includes a substitution at amino acid 1064. In some 
embodiments, the at least one amino acid mutation includes a 
substitution at amino acid 1064 from arginine to tryptophan. 
The plant cellulose from the plant expressing the CESA 
polypeptide variant has an measurable increase in sacchari 
?cation ef?ciency relative to a Wild type plant. In some 
embodiments, the plant cellulose has at least about a 1%, 2%, 
3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 
15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 
25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 
35%, 36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, 
45%, 46%, 47%, 48%, 49%, 50%, 51%, 52%, 53%, 54%, 
55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 
65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 
75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 
85%, or more increase in sacchari?cation ef?ciency relative 
to the Wild type plant. In some embodiments, the plant cellu 
lose has at least about a 10%, 11%, 12%, 13%, 14%, 15%, 
16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 
26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 
36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, 45%, 
46%, 47%, 48%, 49%, 50%, or more decrease in relative 
crystallinity relative to the Wild type plant. 
In some embodiments, the plant is a plant selected from: 
Andropogon, Arabidopsis, Araucaria, Arundo, Aspidislra, 
Belula, Brachypodium, Chasmanlhium, Cyanodon, Cynara, 
Eragroslis, Eucalyptus, Fesluca, Miscanlhus, Muhlenbergia, 
Nicotiana, Oryza, Panicum, Phalaris, Pinus, Pisum, Plata 
nus, Podocarpus, Populus, Saccharum, Salix, Solanum, 
Sorghaslrum, Sorghum, Spenlina, T ripsacum, and Zea. 
The presently-disclosed subject matter includes a method 
of processing plant cellulose, Which includes measuring a 
relative crystallinity index of plant cellulose, providing the 
plant cellulose if the relative crystallinity index is indicative 
of bene?cial sacchari?cation properties, and saccharifying 
the plant cellulose to produce ferrnentable sugars. In some 
embodiments, the method also includes fermenting the fer 
mentable sugars to produce alcohol. 
In some embodiments, the relative crystallinity index that 
is indicative of bene?cial sacchari?cation properties is about 
a10%,11%,12%,13%,14%,15%,16%,17%,18%,19%, 
20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%, 
30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39%, 
40%, 41%, 42%, 43%, 44%, 45%, 46%, 47%, 48%, 49%, 
50%, or more decrease in relative crystallinity relative to the 
Wild type plant. 
In some embodiments, the a plant expresses a CESA 
polypeptide variant having at least one amino acid mutation 
in its carboxy-terminal transmembrane region. 
The presently-disclosed subject matter includes a method 
of producing a plant having bene?cial sacchari?cation prop 
erties, Which includes introducing into a plant a polynucle 
otide encoding a CESA polypeptide variant having at least 
one amino acid mutation in its carboxy-terminal transmem 
brane region, and expressing in the plant the CESA polypep 
tide variant, Wherein the plant expressing the CESA polypep 
tide variant produces plant cellulose having bene?cial 
sacchari?cation properties as compared to plant cellulose 
produced by a Wild-type plant. 
In some embodiments, introducing the polynucleotide into 
the plant comprises transforming at least one cell of the plant 
With a heterologous polynucleotide encoding the CESA 
polypeptide variant. Such introduction can be accomplished 
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by molecularbiology methods knoW to those skilled in the art. 
In some embodiments, introducing the polynucleotide into 
the plant comprises applying a compound to a plant to create 
a mutation in the polynucleotide, such that the polypeptide 
encodes the CESA polypeptide variant having at least one 
amino acid mutation in its carboxy-terminal transmembrane 
region. In some embodiments, the compound is a herbicide to 
Which the produced plant is resistant. In some embodiments, 
the compound is isoxaben. Such introduction can be accom 
plished using forWard genetics and selection techniques 
knoWn to those skilled in the art. 
In some embodiments, the plant is a plant selected from: 
Andropogon, Arabidopsis, Araucania, Arundo, Aspidislra, 
Belula, Brachypodium, Chasmanlhium, Cyanodon, Cynara, 
Eragroslis, Eucalyptus, Fesluca, Miscanlhus, Muhlenbergia, 
Nicoliana, Oryza, Panicum, Phalaris, Pinus, Pisum, Plala 
nus, Podocarpus, Populus, Saccharum, Salix, Solanum, 
Sorghaslrum, Sorghum, Spenlina, T ripsacum, and Zea. 
In some embodiments, the CESA polypeptide variant is a 
CESA selected from: CESA-1 polypeptide variant, CESA-2 
polypeptide variant, CESA-3 polypeptide variant, CESA-4 
polypeptide variant, CESA-5 polypeptide variant, CESA-6 
polypeptide variant, CESA-7 polypeptide variant, CESA-8 
polypeptide variant, CESA-9 polypeptide variant, and 
CESA-10 polypeptide variant. In some embodiments, the 
CESA polypeptide variant is a CESA selected from: CESA-1 
polypeptide variant, CESA-3 polypeptide variant, and 
CESA-6 polypeptide variant. In some embodiments, the 
CESA polypeptide variant is a CESA selected from: CESA-1 
polypeptide variant and CESA-3 polypeptide variant. In 
some embodiments, the CESA polypeptide variant is 
CESA-1 polypeptide variant. In some embodiments, the 
CESA polypeptide variant is CESA-3 polypeptide variant. 
In some embodiments, the CESA polypeptide variant 
includes at least one substitution at an amino acid from 840 
1065 of the CESA polypeptide, Where residue numbers 840 
1065 refer to those residues of full-length Wild type CESA 
polypeptide. In some embodiments, the CESA polypeptide 
variant includes at least one substitution at an amino acid 
from 900-1065. For example, in some embodiments, the at 
least one amino acid mutation includes a substitution at 
amino acid 942. In some embodiments, the at least one amino 
acid mutation includes a substitution at amino acid 942 from 
threonine to isoleucine. In some embodiments, the at least 
one amino acid mutation includes a substitution at amino acid 
998. In some embodiments, the at least one amino acid muta 
tion includes a substitution at amino acid 998 from glycine to 
aspartic acid. In some embodiments, the at least one amino 
acid mutation includes a substitution at amino acid 903. In 
some embodiments, the at least one amino acid mutation 
includes a substitution at amino acid 903 from alanine to 
valine. In some embodiments, the at least one amino acid 
mutation includes a substitution at amino acid 1064. In some 
embodiments, the at least one amino acid mutation includes a 
substitution at amino acid 1064 from arginine to tryptophan. 
The plant cellulose from the plant expressing the CESA 
polypeptide variant has an measurable increase in sacchari 
?cation ef?ciency relative to a Wild type plant. In some 
embodiments, the plant cellulose has at least about a 1%, 2%, 
3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 
15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 
25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 
35%, 36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, 
45%, 46%, 47%, 48%, 49%, 50%, 51%, 52%, 53%, 54%, 
55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 
65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 
75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 
US 8,383,888 B1 
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85%, or more increase in sacchari?cation ef?ciency relative 
to the Wild type plant. In some embodiments, the plant cellu 
lose has at least about a 10%, 11%, 12%, 13%, 14%, 15%, 
16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 
26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 
36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, 45%, 
46%, 47%, 48%, 49%, 50%, or more decrease in relative 
crystallinity relative to the Wild type plant. 
The presently-disclosed subject matter includes a compo 
sition comprising plant cellulose having bene?cial sacchari 
?cation properties, Wherein the plant cellulose is from a plant 
expressing a CESA polypeptide variant having at least one 
amino acid mutation in its carboxy-terminal transmembrane 
region. In some embodiments, the composition is used to 
produce a biofuel. In some embodiments, the composition is 
used as a feedstock. 
The plant cellulose from the plant expressing the CESA 
polypeptide variant has an measurable increase in sacchari 
?cation ef?ciency relative to a Wild type plant. In some 
embodiments, the plant cellulose has at least about a 1%, 2%, 
3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 
15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 
25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 
35%, 36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, 
45%, 46%, 47%, 48%, 49%, 50%, 51%, 52%, 53%, 54%, 
55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 
65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 
75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 
85%, or more increase in sacchari?cation ef?ciency relative 
to the Wild type plant. In some embodiments, the plant cellu 
lose has at least about a 10%, 11%, 12%, 13%, 14%, 15%, 
16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 
26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 
36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, 45%, 
46%, 47%, 48%, 49%, 50%, or more decrease in relative 
crystallinity relative to the Wild type plant. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 includes a schematic representation of the general 
structure of the plant cell Wall matrix With emphasis on cel 
lulose. FIG. 1A includes a simpli?ed version of the primary 
cell Wall (PCW); FIG. 1B includes a depiction of the second 
ary cell Wall (SCW); FIG. 1C includes a schematic of the 
production of cellulose having bene?cial sacchari?cation 
properties. FIG. 1D includes a molecular model of the CESA 
membrane rosette shoWing the molecular con?guration of a 
single rosette subunit (left) and the complete CESA rosette 
(right). 
FIG. 2 is a schematic draWing of a CESA protein shoWing 
mutations effecting RCI and sacchari?cation e?iciency 
Within the carboxy-terminal transmembrane domain of the 
CESA. FIG. 2 further shoWs various functional regions of the 
CESA protein and the interaction of the protein With the cell 
membrane. 
FIG. 3 is a sequence alignment of CESA3 from Arabidop 
sis With CESA1 and CESA3 proteins from other plant species 
(SEQ ID NOS: 4-9). The alignment demonstrates the high 
level of conservation betWeen different CESA as Well as 
CESA3 across species, and in particular in the region of 
mutation determined relevant for reducing RCI. In particular, 
it is noted that threonine 942 is completely conserved across 
CESA proteins and species. It is predicted that T942 is a vital 
phosphorylation site and When changed to isoleucine (as dis 
closed hereiniT942I) is non functional. 
FIG. 4 is a schematic draWing shoWing alignment of the 
different family members of Arabidopsis CESA family mem 
20 
25 
30 
35 
40 
45 
50 
55 
60 
65 
6 
bers at functional domains. Note in particular the high degree 
of functional homology at the carboxy-terminal transmem 
brane domain. 
FIGS. 5A and 5B are bar graphs shoWing improved bio 
chemical conversion of dry biomass into fermentable sugars 
in the cell Wall mutants. FIG. 5A shoWs analysis of various 
Arabidopsis plants carrying mutations in a number of genes 
critical to cellulose biosynthesis by hydrolytic enZyme sac 
chari?cation e?iciency. The graph plots fermentable sugars 
released relative to the conversion rate of Wild type biomass 
as a percentage (n:3) FIG. 5B plots the relative crystallinity 
index (RCI) of the biomass sample measured by x-ray dif 
fraction (n:3). 
FIG. 6 is a bar graph plotting the fermentable sugars enZy 
matically released from Wild type versus mutant as absolute 
values. Absolute values are the percent of total cellulose 
converted to fermentable in 24 hours using 60 FPU of enZyme 
(11:3) 
FIGS. 7A-7D are line graphs shoWing sacchari?cation e?i 
ciency reported as % oftotal glucose released at 2, 4, 6, 12, 24, 
48, and 168 hours using (A) 7.5, (B) 15, (C) 30 and (D) 60 
FPU of enZyme from Wild type (dashed line) and ixr1 -2 (solid 
line) (error bars n:4). 
FIG. 8 is a line graph shoWing initial rate of sugar release 
from biomass by the enZyme mixture as a function of cellu 
lose concentration. Wild type biomass closed circles and 
dashed line and ixr1-2 closed squares and solid line (error 
bars n:3). 
FIG. 9 is a bar graph shoWing a consistent 50% improve 
ment in the ixr1-2 mutant over bioconversion of Wild type 
lignocellulosic biomass in batch and time comparison stud 
ies. 
FIG. 10 includes schematic map of the plant expression 
constructs (pKM24-CESA3-1, pKM24-CESA3-2, pKM24 
CESA3-3) With the chimeric CESA3 gene (GenBank acces 
sion no. NM120599). 
FIG. 11 includes the results of Wide angle synchrotron 
analysis used to study structural changes in cellulose derived 
from a ixr1-2 plant, as compared to cellulose derived from a 
control plant. 
BRIEF DESCRIPTION OF THE SEQUENCE 
LISTING 
SEQ ID NO: 1 is a Wild type polynucleotide sequence 
encoding a CESA-3 polypeptide from Arabidopsis Zhaliana. 
SEQ ID NO: 2 is a Wild type polypeptide sequence of a 
CESA-3 polypeptide from A. Zhaliana. 
SEQ ID NO: 3 polypeptide sequence of a CESA-3 
polypeptide having a T942I mutation. 
SEQ ID NO: 4 is a polypeptide sequence ofa portion ofa 
CESA-3 from Belula pendula, presented in alignment With 
other CESA polypeptides in FIG. 3. 
SEQ ID NO: 5 is a polypeptide sequence ofa portion ofa 
CESA-3 from Zea mays, presented in alignment With other 
CESA polypeptides in FIG. 3. 
SEQ ID NO: 6 is a polypeptide sequence ofa portion ofa 
CESA-3 from Arabidopsis Zhaliana, presented in alignment 
With other CESA polypeptides in FIG. 3. 
SEQ ID NO: 7 is a polypeptide sequence ofa portion ofa 
CESA-1 from Arabidopsis Zhaliana, presented in alignment 
With other CESA polypeptides in FIG. 3. 
SEQ ID NO: 8 is a polypeptide sequence ofa portion ofa 
CESA-3 from Populus Zrichocarpa, presented in alignment 
With other CESA polypeptides in FIG. 3. 
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SEQ ID NO: 9 is a polypeptide sequence of a portion of a 
CESA3 from Solanum lycopersicum, presented in alignment 
With other CESA polypeptides in FIG. 3. 
DESCRIPTION OF EXEMPLARY 
EMBODIMENTS 
The details of one or more embodiments of the presently 
disclosed subject matter are set forth in this document. Modi 
?cations to embodiments described in this document, and 
other embodiments, Will be evident to those of ordinary skill 
in the art after a study of the information provided in this 
document. The information provided in this document, and 
particularly the speci?c details of the described exemplary 
embodiments, is provided primarily for cleamess of under 
standing and no unnecessary limitations are to be understood 
therefrom. In case of con?ict, the speci?cation of this docu 
ment, including de?nitions, Will control. 
The presently-disclosed subject matter includes a method 
of processing plant cellulose, and a biofuel produced by the 
method of processing plant cellulose. The presently-dis 
closed subject matter further includes a method of producing 
a plant having bene?cial sacchari?cation properties, and a 
plant having bene?cial sacchari?cation properties. The pres 
ently-disclosed subject matter further includes a composition 
comprising plant cellulose having bene?cial sacchari?cation 
properties, Which composition can be used to produce a bio 
fuel or as feedstock. Such feedstock can have improved 
digestibility and dietary ef?ciency in ruminants, e.g., cattle. 
The basic steps of converting plant cellulose or biomass to 
a bio fuel include saccharifying the plant cellulose, and fer 
menting the sugars that are obtained from the sacchari?cation 
of the cellulose. The conversion of plant cellulose to ferment 
able sugars is often referred to as sacchari?cation or hydroly 
s1s. 
The term “biofuel”, as used herein, refers to a fuel that is 
produced from plant material. Alcohol (e.g., ethanol) is an 
example of a biofuel. 
“Plant cellulose” is a complex polysaccharide component 
of a plant that includes a plurality of bonded glucose units. As 
is Well knoWn, the glucose units of plant cellulose are typi 
cally connected throughboth glycosidic bonds Within a single 
cellulose chain, and by hydrogen bonds Within the chain or 
With adjacent cellulose chains, resulting in a strong crystal 
line structure. 
The term “biomass”, as used herein, refers to a plant prod 
uct that comprises plant cellulose. As such, unless indications 
are made to the contrary, When methods herein are described 
as making use of plant cellulose, the description is inclusive 
of the methods making use of biomass, because biomass 
comprises plant cellulose. Similarly, unless indications are 
made to the contrary, When compositions herein are described 
as including plant cellulose, the description is inclusive of the 
compositions including biomass, because the biomass com 
prises plant cellulose. 
“Sacchari?cation” refers to the process of breaking a com 
plex carbohydrate, such as cellulose, into its monosaccharide 
components. The monosaccharides or fermentable sugars can 
be utiliZed for fermentation and the production of ethanol, or 
for other biomass energy sources and uses (e.g., as forage 
materials). As noted herein, the intrinsic highly ordered and 
crystalline nature of cellulose makes it recalcitrant to saccha 
ri?cation. 
One of the most challenging obstacles to overcome in 
?nding an ef?cient and cost-effective method of producing 
bio fuels is the dif?culty in ef?ciently saccharifying plant 
cellulose, Which results from the molecular architecture of the 
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cellulose polymers making up plant cell Walls. Modi?cations 
to the processes of cellulose and cell Wall biosynthesis in 
plants offer great potential for enhancing the ease of cellulo 
sic conversion to fermentable sugars, increasing overall 
yields of released sugars, and decreasing overall conversion 
costs. HoWever, the possibility of creating “?awed” or 
“Wounded” cellulose better amenable to enzymatic hydroly 
sis by genetic means has been considered highly challenging 
to plant scientists. It has been noted in the literature that 
although changing the nature of cellulose to be more acces 
sible to enZymatic hydrolysis Would be of potential bene?t, it 
Was further noted that such a process Would be very dif?cult 
and that it is uncertain Whether such a plant Would survive and 
thrive. (l 8). 
The present inventors have surprisingly determined that 
bene?cial sacchari?cation properties can be conferred to cel 
lulose of a plant, as Will be further described herein. 
In some embodiments, a method of producing a plant hav 
ing bene?cial sacchari?cation properties includes introduc 
ing into a plant a polynucleotide encoding a CESA polypep 
tide variant having at least one amino acid mutation in its 
carboxy-terminal transmembrane region; and expressing in 
the plant the CESA polypeptide variant, Wherein plant cellu 
lose of the plant expressing the CESA polypeptide variant has 
bene?cial sacchari?cation properties as compared to a Wild 
type plant. 
As used herein, the term “plant” includes reference to 
Whole plants, plant parts or organs (e. g., leaves, stems, roots, 
etc.), plant cells, seeds and progeny of same. Plant cell, as 
used herein includes, Without limitation, cells obtained from 
or found in: seeds, suspension cultures, embryos, meristem 
atic regions, callus tissue, leaves, roots, shoots, gameto 
phytes, sporophytes, pollen, and microspores. Plant cells can 
also be understood to include modi?ed cells, such as proto 
plasts, obtained from the aforementioned tissues. The class of 
plants Which canbe used in the methods of the present subject 
matter is generally as broad as the class of higher plants 
comprising signi?cant cellulosic materials, including both 
monocotyledonous and dicotyledonous plants. In some 
embodiments, a plant of interest is a plant selected from the 
group consisting of Andropogon, Arabidopsis (e.g., Arabi 
dopsis Zhaliana), Araucania, Arundo (e.g., Arundo donax), 
Aspidislra, Belula (e.g., Belula pendula), Brachypodium, 
Chasmanlhium, Cyanodon, Cynara, Eragroslis, Eucalyptus, 
Fesluca, Miscanlhus, Muhlenbergia, Nicoliana, Oryza, Pani 
cum (e.g., Panicum virgalum), Phalaris, Pinus, Pisum, Pla 
Zanus, Podocarpus, Populus (e.g., Populus Zremuloides, 
Populus Zrichocarpa), Saccharum, Salix, Solanum (e.g., 
Solanum lycopersicum), Sorghaslrum, Sorghum, Spenlina, 
Tripsacum (e.g., Tripsacum daclyloides), and Zea (e.g., Z. 
mays). In some embodiments, the method of producing a 
plant having bene?cial sacchari?cation properties makes use 
of a plant selected from the group consisting of tree genus 
such as Populus, Plalanus, Pinus, Eucalyptus and Salix spp. 
as Well as grasses, of the family Poaceae, such as Miscanlhus, 
Tripsicum, Panicum, Zea, and Oryza. The preferred plant 
species Will embody ideal groWth rates for bioenergy agricul 
ture and pulp and paper production. 
The terms “polynucleotide” and “nucleic acid” refers to 
deoxyribonucleotides or ribonucleotides and polymers 
thereof in either single or double stranded form. Unless oth 
erWise indicated, a particular nucleic acid sequence also 
implicitly encompasses conservatively modi?ed variants 
thereof (e.g., degenerate codon substitutions) and comple 
mentary sequences and as Well as the sequence explicitly 
indicated. Speci?cally, degenerate codon substitutions can be 
achieved by generating sequences in Which the third position 
US 8,383,888 B1 
of one or more selected (or all) codons is substituted With 
mixed base and/ or deoxyinosine residues (BatZer et al. (1991) 
Nucleic Acid Res 19: 5081; Ohtsuka et al. (1985) J Biol Chem 
260:2605 2608; Rossolini et al. (1994) M01 Cell Probes 8:91 
98). 
The terms “polypeptide,” “protein,” and “peptide,” Which 
are used interchangeably herein, refer to a polymer of the 20 
protein amino acids, or amino acid analogs, regardless of its 
siZe or function. Although “protein” is often used in reference 
to relatively large polypeptides, and “peptide” is often used in 
reference to small polypeptides, usage of these terms in the art 
overlaps and varies. The term “polypeptide” as used herein 
refers to peptides, polypeptides, and proteins, unless other 
Wise noted. The terms “protein,” “polypeptide,” and “pep 
tide” are used interchangeably herein When referring to a gene 
product. Thus, exemplary polypeptides include gene prod 
ucts, naturally occurring proteins, homologs, orthologs, para 
logs, fragments and other equivalents, variants, and analogs 
of the foregoing. 
The term “variant” refers to an amino acid sequence that is 
different from the reference polypeptide by one or more 
amino acids. For example, in some embodiments, the amino 
acid sequence of the variant can differ by one or more amino 
acid mutations, including amino acid substitutions. For 
another example, in some embodiments, the amino acid 
sequence of the variant can differ by the insertion of one or 
more amino acids. For yet another example, in some embodi 
ments the amino acid sequence of the variant can differ by the 
deletion of one or more amino acid sequences. As such, a 
“CESA polypeptide variant” is an amino acid sequence that 
differs from the reference polypeptide, CESA polypeptide, 
by one or more amino acids. As used herein, the term “muta 
tion” means a change, inherited, naturally occurring, or intro 
duced, in a nucleic acid or polypeptide sequence, including a 
change from one or more nucleic acids or amino acids in the 
Wild type sequence to different one or more nucleic acids or 
amino acids in the variant; the insertion of one or more 
nucleic acids or amino acids into the Wildtype sequence, such 
that the variant includes one or more additional nucleic acids 
or amino acids relative to the Wild type sequence; or the 
deletion of one or more nucleic acids or amino acids from the 
Wild type sequence, such that the variant includes one or more 
feWer nucleic acids or amino acids relative to the Wild type 
sequence. 
A variant can also be a “functional variant,” in Which case 
the polypeptide is capable of affecting bene?cial change in 
sacchari?cation properties, e.g., increased sacchari?cation 
e?iciency. A functional variant of a Wild-type reference 
polypeptide has an enhanced ability, relative to the reference 
polypeptide, to confer bene?cial change in sacchari?cation 
properties. As such, a CESA polypeptide variant that confers 
bene?cial sacchari?cation properties to cellulose of a plant, 
as compared to a Wild type CESA polypeptide, is a functional 
variant. In this regard, for a CESA polypeptide variant that 
differs from the reference polypeptide by the insertion of one 
or more amino acids (“insertion variant”), the number of 
amino acids that can be inserted can be about 1, 2, 3, 4, 5, 6, 
7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 
25, 26, 27, 28, 29, or 30. A functional variant can further 
include conservatively substituted variants. The term “con 
servatively substituted variant” refers to a polypeptide com 
prising an amino acid residue sequence that differs from a 
reference polypeptide by one or more conservative amino 
acid substitutions, and exhibits bene?cial sacchari?cation 
properties. The phrase “conservatively substituted variant” 
also includes polypeptides Wherein a residue is replaced With 
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a chemically derivatiZed residue, provided that the resulting 
polypeptide is capable of affecting an increase in sacchari? 
cation ef?ciency. 
A “conservative amino acid substitution” is a substitution 
of an amino acid residue With a functionally similar residue. 
Examples of conservative substitutions include the substitu 
tion of one non-polar (hydrophobic) residue such as isoleu 
cine, valine, leucine or methionine for another; the substitu 
tion of one charged or polar (hydrophilic) residue for another 
such as betWeen arginine and lysine, betWeen glutamine and 
asparagine, betWeen threonine and serine; the substitution of 
one basic residue such as lysine or arginine for another; the 
substitution of one acidic residue, such as aspartic acid or 
glutamic acid for another; or the substitution of one aromatic 
residue, such as phenylalanine, tyrosine, or tryptophan for 
another. 
Conversely, a “non-conservative amino acid substitution” 
is a substitution of an amino acid residue With a functionally 
dissimilar residue. For example, a nonconservative substitu 
tion includes the substitution of a non-polar (hydrophobic) 
residue such as isoleucine, valine, leucine, or methionine, 
With a charged or polar (hydrophilic) residue such as arginine, 
lysine, glutamine, asparagine, threonine, or serine. 
By Way of providing an example With regard to non-con 
servative amino acid substitutions, in some embodiments, a 
CESA polypeptide variant includes a mutation from threo 
nine to isoleucine. The CESA polypeptide variant can be 
described as including a mutation that involves a non-conser 
vative amino acid substitution, because threonine, Which is 
generally hydrophilic, can be described as functionally dis 
similar from isoleucine, Which is generally hydrophobic. For 
anther example, a CESA polypeptide variant including a 
mutation from glycine to aspartic acid can be described as 
including a mutation that involves a non-conservative amino 
acid substitution, because glycine, Which is generally nonpo 
lar, can be described as functionally dissimilar from aspartic 
acid, Which is charged. For anther example, a CESA polypep 
tide variant including a mutation from arginine to tryptophan 
can be described as including a mutation that involves a 
non-conservative amino acid substitution, because arginine, 
Which is generally polar, can be described as functionally 
dissimilar from tryptophan, Which is nonpolar and aromatic. 
By Way of providing an example With regard to conserva 
tive amino acid substitutions, a conservatively substituted 
variant of a CESA polypeptide variant having a mutation 
from threonine to isoleucine could be a CESA polypeptide 
variant having a mutation from threonine to valine, because 
isoleucine and valine are functionally similar. 
The terms “polypeptide fragment” or “fragment,” When 
used in reference to a polypeptide, refers to a polypeptide in 
Which amino acid residues are deleted as compared to the 
reference polypeptide itself, but Where the remaining amino 
acid sequence is usually identical to the corresponding posi 
tions in the reference polypeptide, such as for example a 
native polypeptide. Such deletions can occur at the amino 
terrninus or carboxy-terminus of the reference polypeptide, 
or alternatively both. Such deletions can also occur at a loca 
tion Within the polypeptide that is betWeen the amino-termi 
nus and carboxy-terminus. Fragments typically are at least 
about 50, 60, 70, 80, 90, 100, 110, 120, 130, 140, 150, 160, 
170, 180, 190, 200, 225, 250, or 275 amino acids long. A 
fragment of a reference polypeptide also refers to a fragment 
of a variant of the reference polypeptide, for example, a 
variant Wherein one or more amino acid residues are deleted 
as compared to the variant. A fragment can also be a “func 
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tional fragment,” meaning that the fragment is capable of 
conferring bene?cial sacchari?cation properties to plant cel 
lulose ofa plant. 
As used herein, “CESA” polypeptide refers to the catalytic 
subunits of a plant cellulose synthase enZyme complex. With 
reference to FIG. 1, and particularly With reference to FIG. 
1D, Cellulose is synthesized in higher plants via a multimeric 
plasma membrane-localized complex that can be visualiZed 
as symmetrical rosettes of six globular complexes approxi 
mately 25-30 nm in diameter. Further, it is appreciated that 
plants contain multiple CESA proteins. For example, the 
CESA gene family in Arabidopsis contains 10 family mem 
bers, termed CESA-1 to CESA-10, and each shoWs different 
patterns of expression and different functional characteris 
tics. 
Reference is made to FIG. 1, Which includes a schematic 
representation of the general structure of the plant cell Wall 
matrix With emphasis on cellulose. FIG. 1A provides a sim 
pli?ed version of the primary cell Wall (PCW), shoWn as a 
netWork of cellulose micro?brils (CM) interlocked and 
coated by cross-linking hemicelluloses (HC), Which are pri 
marily xyloglucans (XG) in Type I Walls and glucuronoara 
binoxylans (GAX) in Type II Walls. Together, CMs and HCs 
are embedded in a matrix of pectin (Type I) or acidic polysac 
charides (Type II) With various levels of proteins (not shoWn) 
that aid in Wall structure, assembly and degradation (Vergara 
and Carpita, 2001). Cellulose is being synthesiZed at the 
plasma membrane (PM) by a symmetrical rosette of six 
globular cellulose synthase (CESA) protein complexes 
(BroWn, 1996, Herth, 1983). The CESA rosette incorporates 
UDP-glucose molecules, present in the cytosol, into groWing 
[3-1,4-linked glucan chains, a total of 36 of Which are pro 
duced by a single rosette Which then cocrystalliZe to form a 
single micro?bril (Herth, 1983). Occasionally, the glucan 
chains are thought to form less ordered regions that structur 
ally forrn amorphous Zones along the length of the CM, rather 
than crystalline regions (O’ Sullivan, 1997), Which may serve 
as speci?c connection points betWeen the cross-linking HCs 
and the CM (Himmel et al., 2007). The precise architecture of 
the CESA rosette complex and the identity of possible pro 
teins With Which it interacts at the cytosolic and extracellular 
PM surface have yet to be resolved. For this reason, and 
because most of the proteins, including the catalytic domains, 
extend into the cytoplasm, the CESA complex is depicted as 
a nebulous, ill-de?ned structure in the cytosol. HCs and pec 
tin are shoWn being delivered, prefabricated, to the cell Wall 
matrix through the PM via a Golgi secretory vesicle. 
Turning noW to FIG. 1B, the secondary cell Wall (SCW) is 
produced by certain cell types as part of the maturation pro 
cess after groWth has ceased and consists primarily of CMs, 
HCs and lignin. Ligni?cation results in the coating of CMs 
With anhydrous lignin polymers that further strengthen the 
cell Wall but also present a major barrier in the bioconversion 
process to biofuels by blocking access and causing adsorption 
of hydrolytic enZymes (Moiser et al., 2005). 
FIG. 1C includes a schematic of the production of cellulose 
having bene?cial sacchari?cation properties. Cellulose crys 
tallinity is another important factor contributing to the recal 
citrant nature of most lignocellulosic biomass to enzymatic 
degradation (Moiser et al., 2005). Genetic modi?cation of 
various CESA proteins has been shoWn to reduce the crystal 
linity of the lignocellulosic biomass and enhance enZymatic 
degradation (Harris et al., 2009). Without Wishing to be 
bound by theory or mechanism, this phenomenon could occur 
through the creation of more amorphous regions Within the 
cellulose micro?bril or by causing a proportional shift in the 
volume fraction of the cell Wall betWeen the cellulose, hemi 
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cellulose and lignin fractions. Here the glucan chains pro 
duced by the different CESA protein are color coordinated to 
match FIG. 1D. 
FIG. 1D includes a molecular model of the CESA mem 
brane rosette shoWing the molecular con?guration of a single 
rosette subunit (left) and the complete CESA rosette (right). 
Each rosette subunit is identical, consisting of one molecule 
of a1, tWo molecules of (X2 and three molecules of [3 type 
CESA proteins (Ding and Himmel, 2006). Only three pos 
sible types of protein-protein interactions are necessary (otl - 
[3, (x2-[3, and [3-[3) for rosette assembly in the plasma mem 
brane or for rosette-rosette interaction to constitute the array 
formation seen in the parenchyma cells of maiZe stem pith 
(not shoWn) (Ding and Himmel, 2006). Interchangeable ver 
sus compulsory CESA subunits in the primary cell Wall 
CESA complex are de?ned as CESAl and CESA3 are com 
pulsory and CESA 2, 5, 7, 9, and 10 are interchangeable. For 
the secondary cell Wall CESA complex CESA4, 7 and 8 are 
all necessary components for correct secondary cell Wall 
cellulose synthesis. Figure not to scale (adapted from Harris 
and DeBolt, 2009 Plant Biotechnology Journal). 
With reference to FIG. 4, each of these CESA polypeptides 
exhibit high homology to one another, particularly With the 
carboxy-terrninal transmembrane region. In some embodi 
ments, the method of producing a plant having bene?cial 
sacchari?cation properties includes expressing a CESA 
polypeptide variant selected from the group consisting of: 
CESA-1 polypeptide variant, CESA-2 polypeptide variant, 
CESA-3 polypeptide variant, CESA-4 polypeptide variant, 
CESA-5 polypeptide variant, CESA-6 polypeptide variant, 
CESA-7 polypeptide variant, CESA-8 polypeptide variant, 
CESA-9 polypeptide variant, and CESA-10 polypeptide vari 
ant. In some embodiments, the method of producing a plant 
having bene?cial sacchari?cation properties includes 
expressing a CESA polypeptide variant selected from the 
group consisting of: CESA-1 polypeptide variant, CESA-3 
polypeptide variant, CESA-6 polypeptide variant. In some 
embodiments, the method of producing a plant having ben 
e?cial sacchari?cation properties includes expressing a 
CESA polypeptide variant selected from the group consisting 
of: CESA-1 polypeptide variant and CESA-3 polypeptide 
variant. In some embodiments, a plant having bene?cial sac 
chari?cation properties includes expressing more than one 
CESA polypeptide variant. For example, in some embodi 
ments, a plant having bene?cial sacchari?cation properties 
can express a CESA-3 polypeptide variant and a CESA-1 
polypeptide variant. 
In some embodiments, the method of producing a plant 
having bene?cial sacchari?cation properties includes 
expressing a CESA polypeptide variant having at least one 
amino acid mutation in its carboxy-terminal transmembrane 
region, Wherein the carboxy-terminal transmembrane region 
refers to amino acids 840-1065 of a full length Wild-type 
CESA polypeptide. In some embodiments, the carboxy-ter 
minal transmembrane region of a CESA polypeptide refers to 
amino acids 900-1065. 
Using CESA-3 (SEQ ID NO: 2) as an initial example, 
amino acids 840-1065 can be identi?ed as the carboxy-ter 
minal transmembrane region of CESA-3, the same region in 
any other CESA polypeptide can be selected as the carboxy 
terminal transmembrane region. Indeed, the identi?ed resi 
dues of 840-1065 in CESA-3 Would translate into the other 
CESA polypeptides, With additions or subtractions of less 
than ?fteen, less than ten, less than ?ve, less than tWo, or no 
residues, because of the high conservation betWeen CESA 
polypeptides in the, particularly in the carboxy-terminal 
transmembrane region. For example, the 840-1065 region of 
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CESA-3 is equivalent to the 840-1065 region of CESA-1 . For 
another example, the 840-1065 region of CESA-3 is equiva 
lent to the 840-1065 region of CESA-6. As such, When amino 
acids 840-1065, for example, are identi?ed as the carboxy 
terminal transmembrane region, this identi?cation is relevant 
to any CESA polypeptide, including CESA-1, CESA-2, 
CESA-3, CESA-4, CESA-5, CESA-6, CESA-7, CESA-8, 
CESA-9, and CESA-10. 
Further, CESA polypeptides are highly conserved at the 
C-terminal transmembrane region across plant species and 
therefore gene and protein orthologs from other plant species 
are intended to be included in the presently-disclosed subject 
matter. As such, identi?ed residues of 840-1065, for example, 
in a CESA polypeptide of one plant Would translate into the 
CESA polypeptides of other plants, With additions or subtrac 
tions of less than ?fteen, less than ten, less than ?ve, less than 
tWo, or no residues, because of the high conservation betWeen 
CESA polypeptides in the, particularly in the carboxy-termi 
nal transmembrane region. For another example, identi?ed 
residues of 840-1065 in a CESA-3 of one plant Would trans 
late into the CESA-3 of other plant species. For another 
example, identi?ed residues of 840-1065 in a CESA-1 or 
CESA-3 of one plant Would translate into the CESA-1 or 
CESA-3 of other plant species. For example, When amino 
acids 840-1065 are identi?ed as the carboxy-terminal trans 
membrane region, this identi?cation refers to a CESA 
polypeptide of any plant species, including, but not limited to 
Arabidopsis, Belula, Cynara, Zea, Solanum, Nicoliana, 
Populus, Panicum, Podocarpus, Araucaria, Aspidislra, 
Pisum, Arundo donax, Miscanlhus, Cyanodon, Phalaris, 
Eragroslis, T ripsacum daclyloides, Plalanus, Pinus, Plaza 
nus, Festuca, Spentina, Saccharum, Eucalyptus, Chasman 
Zhium, Sorghaslrum, Muhlenbergia, Salix, Andropogon, 
Brachypodium, Oryza, and Sorghum. FIG. 3 exempli?es the 
homology of CESA polypeptides betWeen plant species, 
shoWing a sequence alignment demonstrating high sequence 
identity across polypeptide sequences in the CESA carboxy 
terminal transmembrane region. Thus, When a CESA 
polypeptide is referenced herein, it is intended that all knoWn 
CESA polypeptides are includes in the reference, across plant 
species and When a particular CESA polypeptide subunit 
(e.g., CESA-3) is referenced, it is intended that all knoWn 
CESA-3 polypeptides across plant species are included in the 
reference. 
With reference to FIG. 2, in some embodiments, the meth 
ods comprise introducing into a plant a polynucleotide encod 
ing a CESA polypeptide variant having at least one amino 
acid mutation Within a carboxy-terminal transmembrane 
region of the CESA. In some embodiments, the CESA 
polypeptide variant includes tWo or more amino acid muta 
tions Within a carboxy-terminal transmembrane region of the 
CESA. In some embodiments, the at least one mutation can be 
an amino acid substitution at a residue Within the carboxy 
terminal transmembrane region, for example, an amino acid 
substation at amino acid Within the carboxy-terminal trans 
membrane region selected from the folloWing amino acids as 
identi?ed by residue number of a full-length Wild type CESA 
polypeptide: 1065, 1064, 1063, 1062, 1061, 1060, 1059, 
1058,157,1056,1055,1054,1053,1052,1051,1050,1049, 
1048,1047,1046,1045,1044,1043,1042,1041,1040,1039, 
1038,1037,1036,1035,1034,1033,1032,1031,1030,1029, 
1028,1027,1026,1025,1024,1023,1022,1021,1020,1019, 
1018,1017,1016,1015,1014,1013,1012,1011,1010,1009, 
1008, 1007, 1006, 1005, 1004, 1003, 1002, 1001, 1000, 999, 
998, 997, 996, 995, 994, 993, 992, 991, 990, 989, 988, 987, 
986, 985, 984, 983, 982, 981, 980, 979, 978, 977, 976, 975, 
974, 973, 972, 971, 970, 969, 968, 967, 966, 965, 964, 963, 
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962, 961, 960, 959, 958, 957, 956, 955, 954, 953, 952, 951, 
950, 949, 948, 947, 946, 945, 944, 943, 942, 941, 940, 939, 
938, 937, 936, 935, 934, 933, 932, 931, 930, 929, 928, 927, 
926, 925, 924, 923, 922, 921, 920, 919, 918, 917, 916, 915, 
914, 913, 912, 911, 910, 909, 908, 907, 906, 905, 904, 903, 
902, 901, 900, 899, 898, 897, 896, 895, 894, 893, 892, 891, 
890, 889, 888, 887, 886, 885, 884, 883, 882, 881, 880, 879, 
878, 877, 876, 875, 874, 873, 872, 871, 870, 869, 868, 867, 
866, 865, 864, 863, 862, 861, 860, 859, 858, 857, 856, 855, 
854, 853, 852, 851, 850, 849, 848, 847, 846, 845, 844, 843, 
842, 841, and 840. 
In some embodiments, the at least one mutation can be a 
non-conservative amino acid substitution. In some embodi 
ments, the at least one mutation can be a conservative amino 
acid substitution. 
In some embodiments, CESA polypeptide variant includes 
an amino acid substitution at amino acid 942. In some 
embodiments, CESA polypeptide variant includes a substi 
tution at amino acid 942 from threonine to an amino acid 
selected from the group consisting of: isoleucine, valine, 
leucine, and methionine. In some embodiments, CESA 
polypeptide variant includes a substitution at amino acid 942 
from threonine to isoleucine, i.e., T942I, (SEQ ID NO: 3). 
In some embodiments, CESA polypeptide variant includes 
an amino acid substitution at amino acid 998. In some 
embodiments, CESA polypeptide variant includes a substi 
tution at amino acid 998 from glycine to an amino acid 
selected from the group consisting of: aspartic acid and 
glutamic acid. In some embodiments, CESA polypeptide 
variant includes a substitution at amino acid 998 from glycine 
to aspartic acid, i.e., G998D. 
In some embodiments, CESA polypeptide variant includes 
an amino acid substitution at amino acid 903. In some 
embodiments, CESA polypeptide variant includes a substi 
tution at amino acid 903 from alanine to an amino acid 
selected from the group consisting of: valine, isoleucine, 
leucine, and methionine. In some embodiments, CESA 
polypeptide variant includes a substitution at amino acid 903 
from alanine to valine, i.e., A903V. 
In some embodiments, CESA polypeptide variant includes 
an amino acid substitution at amino acid 1064. In some 
embodiments, CESA polypeptide variant includes a substi 
tution at amino acid 1064 from arginine to an amino acid 
selected from the group consisting of: tryptophan, phenyla 
lanine, and tyrosine. In some embodiments, CESA polypep 
tide variant includes a substitution at amino acid 1064 from 
arginine to tryptophan, i.e., R1064W. 
In some embodiments, the CESA polypeptide variant is a 
CESA-3 variant including a substitution at amino acid 942 
from threonine to isoleucine. In some embodiments, the 
CESA polypeptide variant is a CESA-3 variant including a 
substitution at amino acid 998 from glycine to aspartic acid. 
In some embodiments, the CESA polypeptide variant is a 
CESA-1 variant including a substitution at amino acid 903 
from alanine to valine. In some embodiments, the CESA 
polypeptide variant is a CESA-6 variant including a substi 
tution at amino acid 1064 from arginine to tryptophan. 
Creating various mutation variations envisioned by the 
presently-disclosed subject matter can be accomplished by a 
variety of protocols knoWn in the art including those 
described in Us. Pat. No. 6,448,048 issued to Tomono et al., 
on Sep. 20, 2002, Which is incorporated herein by reference in 
its entirety. 
As Will be understood by those skilled in the art, introduc 
ing into a plant a polynucleotide encoding a CESA polypep 
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tide variant, and expressing the CESA polypeptide variant 
can be accomplished using standard molecular biology tech 
niques. 
In some embodiments, “introducing” the polynucleotide 
into the plant comprises transforming at least one cell of the 
plant With a heterologous polynucleotide the polynucleotide 
encoding the CESA polypeptide variant. 
The terms “heterologous”, “recombinant”, and “exog 
enous”, When used herein to refer to a nucleic acid sequence 
(e.g., a DNA sequence) or a gene, refer to a sequence that 
originates from a source foreign to the particular host cell or, 
if from the same source, is modi?ed from its original form. 
Thus, a heterologous gene in a host cell includes a gene that is 
endogenous to the particular host cell but has been modi?ed 
through, for example, the use of site-directed mutagenesis or 
other recombinant techniques. The terms also include non 
naturally occurring multiple copies of a naturally occurring 
DNA sequence. Thus, the terms refer to a DNA segment that 
is foreign or heterologous to the cell, or homologous to the 
cell but in a position or form Within the host cell in Which the 
element is not ordinarily found. Similarly, When used in the 
context of a polypeptide or amino acid sequence, an exog 
enous polypeptide or amino acid sequence is a polypeptide or 
amino acid sequence that originates from a source foreign to 
the particular host cell or, if from the same source, is modi?ed 
from its original form. Thus, exogenous DNA segments can 
be expressed to yield exogenous polypeptides. In contrast, a 
“homologous” nucleic acid (or amino acid) sequence is a 
nucleic acid (or amino acid) sequence naturally associated 
With a host cell into Which it is introduced. 
The terms “associated Wit ”, “operably linked”, and 
“operatively linked” refer to tWo nucleic acid sequences that 
are related physically or functionally. For example, a pro 
moter or regulatory DNA sequence is said to be “operatively 
linked Wit ” a DNA sequence that encodes an RNA or a 
polypeptide if the tWo sequences are operatively linked, or 
situated such that the regulator DNA sequence Will affect the 
expression level of the coding or structural DNA sequence. 
With plant cells, a heterologous polynucleotide, eg a 
polynucleotide encoding a CESA polypeptide variant, can be 
introduced into a plant cell nucleus by methods knoWn to 
those of ordinary skill in the art including, but not limited to, 
methods such as micropipette injection, electroporation, 
polyethylene glycol (PEG) mediated transformation of pro 
toplasts, and gene gun or particle bombardment techniques. 
Further, directed genetic modi?cation and expression of 
heterologous polynucleotides in plants such as Arabidopsis, 
tobacco, etc. can be accomplished by using the T-DNA of the 
Ti plasmid of A grobaclerium Zumefaciens. FolloWing geneti 
cally engineered insertion of a foreign DNA fragment into 
T-DNA inAgrobaclerium, the ho st plant can be transfected by 
the bacterium or Ti plasmid, thus inserting the foreign DNA 
into the host plant chromosome to eventually produce a 
genetically engineered plant. Alternatively Ri, or root-induc 
ing, plasmids may be used as the gene vectors. Although 
A grobaclerium effectively transform only dicots, the Ti plas 
midpermits the ef?cacious manipulation of the bacteria to act 
as vectors in monocotyledonous crop plants, i.e., Wheat, bar 
ley, rice, rye, etc. Alternatively, Ti plasmids or other plasmids 
can be introduced into monocots by arti?cial methods such as 
microinjection, or fusion betWeen the monocot protoplasts 
and bacterial spheroplasts containing the T-region Which 
could then be integrated into the plant nuclear DNA. 
As such, a plant cell of the presently-disclosed subject 
matter can be, for example, a transformed plant cell. The 
terms “transformed”, “transgenic”, and “recombinant” refer 
to a cell, such as a plant cell, into Which a heterologous 
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nucleic acid molecule has been introduced. The nucleic acid 
molecule can be stably integrated into the genome of the cell, 
and/or the nucleic acid molecule can be present as an extra 
chromosomal molecule (e. g., a plasmid). Such an extrachro 
mosomal molecule can be auto-replicating. Transformed 
cells are understood to encompass not only the end product of 
a transformation process, but also transgenic progeny thereof. 
A “non-transformed”, “non-transgenic”, or “non-recombi 
nant” host refers to a Wild type organism, e.g., a cell, Which 
does not contain the heterologous nucleic acid molecule. For 
example, in some embodiments, the cell has been trans 
formed With a plasmid comprising a heterologous expression 
cassette comprising a promoter operatively linked to a gene 
encoding the CESA polypeptide variant. 
The term “expression cassette” refers to a nucleic acid 
molecule capable of directing expression of a particular 
nucleotide sequence in an appropriate host cell, comprising a 
promoter and/or other regulatory sequences operatively 
linked to the nucleotide sequence of interest Which can be 
operatively linked to termination signals. It also typically 
comprises sequences required for proper translation of the 
nucleotide sequence. The coding region usually encodes a 
polypeptide of interest but can also encode a functional RNA 
of interest. The reporter gene cassette comprising the nucle 
otide sequence of interest can be chimeric, meaning that at 
least one of its components is heterologous With respect to at 
least one of its other components. The reporter gene cassette 
can also be one that is naturally occurring but has been 
obtained in a recombinant form useful for heterologous 
expression. 
Typically, hoWever, the reporter gene cassette is heterolo 
gous With respect to the host; i.e., the particular DNA 
sequence of the reporter gene cassette does not occur natu 
rally in the host cell and Was introduced into the host cell or an 
ancestor of the host cell by a transformation event. The 
expression of the nucleotide sequence in the reporter gene 
cassette can be under the control of a constitutive promoter or 
of an inducible promoter that initiates transcription only 
When the host cell is exposed to some particular external 
stimulus. 
The term “gene” is used broadly to refer to any segment of 
DNA associated With a biological function. Thus, genes 
include, but are not limited to, coding sequences and/or the 
regulatory sequences required for their expression. Genes can 
also include non-expressed DNA segments that, for example, 
form recognition sequences for a polypeptide. Genes can be 
obtained from a variety of sources, including cloning from a 
source of interest or synthesiZing from knoWn or predicted 
sequence information, and can include sequences designed to 
have desired parameters. 
In some embodiments, “introducing” the polynucleotide 
into the plant and “expressing” the polypeptide in the plant 
comprises making use of forWard genetics and selection tech 
niques, Which Will be knoWn to those skilled in the art. Brie?y, 
plants containing mutations are provided, and a compound 
(e.g., a herbicide) is applied to the plant. Mutant plants With 
resistance to the herbicide are isolated and the mutation is 
cloned such that it can be identi?ed. When a particular type of 
mutation in a plant is knoWn to be resistant to a particular 
compound (herbicide) such a plant can be isolated from a 
plurality of plants by applying that compound to the plants 
and isolating the compound-resistant plant. For example, cer 
tain plants expressing a CESA polypeptide variant having a 
mutation in its carboxy-terminal transmembrane region have 
been found to be resistant to the herbicide, isoxaben, as is 
described further in the Examples section. It is noted that, if a 
plant expressing a particular CESA polypeptide variant is 
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resistant to a particular herbicide, it Will be resistant to that 
herbicide regardless of Whether the “introducing” of the poly 
nucleotide and the “expressing” of the CESA polypeptide 
variant Was affected by forward genetics techniques or trans 
formation techniques. It is contemplated that introduction 
and expression of the desired CESA polypeptide variant can 
be accomplished by any method capable of accomplishing 
the desired introduction and expression, including forWard 
chemical genetics or transgenic approaches. 
As noted herein, the present inventors surprisingly discov 
ered that cellulose from a plant expressing a CESA polypep 
tide variant having at least one amino acid mutation in its 
carboxy-terminal transmembrane region has bene?cial sac 
chari?cation properties. Bene?cial sacchari?cation proper 
ties refer to properties of a plant or cellulose produced from a 
plant, and particularly, the availability of cellulose from a 
plant for conversion into fermentable sugars (i.e., sacchari? 
cation). Determination of Whether a particular plant, or par 
ticular plant cellulose, has bene?cial sacchari?cation proper 
ties can be accomplished using various methods, including: 
sacchari?cation e?iciency analysis, relative crystallinity 
index analysis, and even high energy synchrotron source 
analysis. 
Sacchari?cation ef?ciency can be measured as a function 
of an amount of fermentable sugar (e.g., glucose) released 
from a cellulose sample exposed to one or more enzymes 
(e.g., cellulases) for a determined time period relative to the 
Weight of the sample (%) and as compared to a Wild-type 
control plant. Standardized enzymatic sacchari?cation pro 
tocols are Well knoWn to those of ordinary skill in the art. One 
exemplary standardized enzymatic sacchari?cation analyti 
cal protocol is provided by the National Renewable Energy 
Laboratory (LAP-009), Which is incorporated herein by ref 
erence. HoWever, the particular sacchari?cation protocol is 
not a controlling factor, as the test cellulose is compared to a 
Wild-type plant control cellulose sample analyzed using an 
identical sacchari?cation protocol. In some embodiments, 
sacchari?cation ef?ciency is expressed as a % increase, cal 
culated using the folloWing formula: % increase:((t—W)/W) 
100, Where t is rate of release for the test plant, and W is rate 
of release for the Wild type plant. In some embodiments, a 
measurable increase in sacchari?cation ef?ciency for a test 
plant, relative to a Wild type plant, is indicative of bene?cial 
sacchari?cation properties of the test plant and the plant cel 
lulose derived therefrom. In some embodiments, a measur 
able increase in sacchari?cation ef?ciency is indicative of 
bene?cial sacchari?cation properties. In some embodiments, 
an increase in sacchari?cation ef?ciency of about 1%, 2%, 
3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 
15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 
25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 
35%, 36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, 
45%, 46%, 47%, 48%, 49%, 50%, 51%, 52%, 53%, 54%, 
55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 
65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 
75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 
85%, or more is indicative of bene?cial sacchari?cation prop 
er‘ties. An exemplary saccari?cation ef?ciency analysis is 
described in the Examples section. 
“Relative crystallinity index” or “RCI” as the terms are 
used herein refer to a relative structural measure of the size, 
density, absolute crystallinity, and/or orientation of cellulose 
in a plant, and in particular, cellulose micro?brils in a plant. 
As set forth in detail in the Examples, RCI can be measured 
using x-ray scattering analysis to measure anx-ray diffraction 
pattern of a sample of cellulose from a plant and measure any 
changes in the orientation, size, or density of the studied 
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cellulose crystallites. The x-ray scattering analysis can be 
performed as set forth in Harris & DeBolt (2008) (13), Which 
is incorporated herein by reference in its entirety. Brie?y, in 
one exemplary procedure, a diffractometer can be used to 
measure x-ray diffraction With Cu KO. radiation generated at 
about 30 mA and about 40 kV. Samples can be analyzed and 
compared to Wild-type control samples to determine the RCI. 
Other procedures can be utilized if desired to measure RCI, 
and the present subject matter is not intended to be limited to 
measurement of RCI by x-ray scattering analysis. For 
example, RCI or elements thereof can also be determined for 
a cellulose sample by measuring transmission geometries 
using a similar x-ray diffractometer as set forth in Andersson 
et al., 2004 (18) orusing a synchrotron x-ray and neutron ?ber 
diffraction analysis as described by Nishimaya et al., 2002 
(1 9). 
Without Wishing to be bound by theory or mechanism, it is 
believed that the CESA polypeptide variants described herein 
are incorporated into the plant cellulose synthase enzyme 
complex to produce cellulose that is “?awed” or “Wounded,” 
as compared to cellulose produced by a Wild type plant. In 
other Words, it is believed that plants expressing the CESA 
polypeptide variants produce cellulose having an altered 
structure With reduced cellulosic crystallinity, from Which 
glucose can be more readily released. In this regard, RCI can 
be correlated to sacchari?cation ef?ciency. A decrease in RCI 
of a test plant (as compared to a Wild-type plant), correlates 
With increased sacchari?cation ef?ciency. 
In this regard, in some embodiments of the presently dis 
closed subject matter, a method of processing plant cellulose 
comprises, measuring the RCI of plant cellulose, providing 
the plant cellulose if the RCI is indicative of bene?cial sac 
chari?cation properties, and saccharifying the plant cellulose 
to produce fermentable sugars. In some embodiments the 
method can further include fermenting the fermentable sug 
ars to produce alcohol. 
In some embodiments, a measurable decrease in RCI for a 
test plant, relative to a Wild type plant, is indicative of ben 
e?cial sacchari?cation properties of the test plant and the 
plant cellulose derived therefrom. In some embodiments, a 
decrease in RCI of about 10%, 11%, 12%, 13%, 14%, 15%, 
16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 
26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 
36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, 45%, 
46%, 47%, 48%, 49%, 50%, or more is indicative ofbene? 
cial sacchari?cation properties. An exemplary x-ray scatter 
ing analysis is described in the Examples section. 
The presently-disclosed subject matter includes a method 
of processing plant cellulose, and a biofuel produced by the 
method of processing plant cellulose. In some embodiments, 
the method of processing plant cellulose, includes providing 
plant cellulose that is from a plant expressing a CESA 
polypeptide variant having at least one amino acid mutation 
in its carboxy-terminal transmembrane region; and sacchari 
fying the plant cellulose or biomass to produce fermentable 
sugars. In some embodiments, the provided plant cellulose is 
from a plant having bene?cial sacchari?cation properties as 
produced by methods of the presently-disclosed subject mat 
ter, described herein. In some embodiments, the method also 
includes fermenting the fermentable sugars to produce alco 
hol, Which can be used as a bio fuel. 
When the term “providing” is used in connection With 
providing plant cellulose for a method described herein, it is 
understood to include providing the plant cellulose by 
directly obtaining it from a plant (e.g., as in the case of a 
farmer or groWer), as Well as providing plant cellulose 
obtained from a third party (e.g., as in the case of a biofuel 





















